Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,928 | -8,730 | -5,196 | -2,780 | -1,369 |
| Depreciation Amortization | 71 | 280 | 213 | 142 | 72 |
| Accounts payable and accrued liabilities | -185 | 1,042 | 275 | -16 | -192 |
| Other Working Capital | 565 | 2,320 | 1,553 | 1,274 | 917 |
| Other Operating Activity | 310 | 868 | 621 | 232 | 408 |
| Operating Cash Flow | $-2,167 | $-4,220 | $-2,534 | $-1,148 | $-164 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -500 | -11 | -11 | -11 |
| Net Acquisitions | N/A | 810 | 44 | N/A | N/A |
| Sale Of Investment | N/A | 815 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -815 | 0 | 0 | 0 |
| Investing Cash Flow | $-15 | $310 | $33 | $-11 | $-11 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 42 | 11,653 | 11,654 | 3,300 | N/A |
| Other Financing Activity | 0 | -3 | 0 | 0 | 0 |
| Financing Cash Flow | $42 | $11,650 | $11,654 | $3,300 | $N/A |
| Beginning Cash Position | 7,996 | 250 | 257 | 257 | 257 |
| End Cash Position | 5,856 | 7,990 | 9,410 | 2,398 | 82 |
| Net Cash Flow | $-2,140 | $7,730 | $9,153 | $2,141 | $-175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,167 | -4,220 | -2,534 | -1,148 | -164 |
| Capital Expenditure | -15 | -500 | -11 | -11 | -11 |
| Free Cash Flow | -2,182 | -4,720 | -2,545 | -1,159 | -175 |